×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs ...
PR Newswire
NRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this...
5 days ago
NRx Pharmaceuticals Breakthrough Drug Shows Potential to Reduce Suicide Risk in Bipolar Depression Patients
MyChesCo
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) disclosed encouraging preliminary outcomes from a study on NRX-101, an investigational...
3 hours ago
NRx Pharmaceuticals Publishes Shareholder Update Letter
GuruFocus
PR NewswireRADNOR, Pa., Sept. 20, 2023 Focus on implications of the recent Data Sharing Agreement relating to a landmark trial of Ketamine in the treatment.
3 days ago
NRx Pharma stresses "promising findings" despite trial miss
The Pharma Letter
Shares in USA-based NRx Pharmaceuticals have fallen by around a fifth, after the firm announced disappointing results from a trial of...
4 days ago
NRx antidepressant fails to reduce depression severity
Fierce Biotech
NRx Pharmaceuticals' investigational antidepressant has failed to reach statistical significance in reducing depression severity in a phase...
5 days ago
NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
PR Newswire
The reverse stock split will become effective at 4:30 p.m. Eastern Time on Monday, April 1, 2024. The Company's common stock will continue to be...
1 month ago
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
PR Newswire
PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical...
2 weeks ago
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated ...
PR Newswire
PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) ("NRx Pharmaceuticals", "NRx", the "Company"), a clinical-stage biopharmaceutical...
2 weeks ago
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
PR Newswire
PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company,...
3 weeks ago
NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug (IND) Application for NRX-101 in the ...
PR Newswire
The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression...
4 months ago